Status: Recruiting
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
This study was a randomized, double-blind, multi-center phase III clinical trial to evaluate the event-free survival (EFS) of Adebrelimab with S-1 and oxaliplatin versus placebo combined with S-1 and oxaliplatin, and to evaluate the efficacy, safety and tolerability of the two combination regimens.
Participants needed: 874
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: May 13, 2026Locations: 1
Eligibility criteria
Patients with pathologically confirmed gastric cancer or gastroesophageal juncti... [+9]
Gastric cancer known to be squamous cell carcinoma, undifferentiated carcinoma o... [+15]